As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
Privia Health Group (NASDAQ:PRVA) reported a strong first quarter, with executives pointing to double-digit provider growth, a larger value-based care population and margin expansion as signs that the company’s operating model continues to scale.
Chief Executive Officer Parth Mehrotra said Privia “
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 25.8% year on ...
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting earnings this Thursday before market open. Here’s what to look for. Privia Health...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:...
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare techno...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Omnicell (NASDAQ:OMCL) and it...
What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ...
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare techno...
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Privia Health has been treading water for the past six months, recording a small loss of 1.6% while holding steady at $22.55. Is there a buying opportunity i...
